drugset / Trial / NCT00112112

Safety Study to Evaluate FluMist in Immunocompromised Children

NCT00112112

Phase 1 Completed 20 enrolled MedImmune LLC
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The main purpose of this study is to get information about the safety of a flu vaccine spray, called FluMist, in children with cancer. The study is also being done to find out how much and how long the vaccine spray can be found in the nose.

Timeline

Start
2005-08-01
Primary completion
2008-03-01
Completion
2008-05-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator FluMist Vaccine 0.5 ml Intranasal

Indications